Effects of Artificial Sweetener on Gastrointestinal (GI) Peptide Secretion
Carbohydrates and Non Caloric Sweeteners: Differential Effects on Appetite and Secretion of Gastrointestinal Satiety Peptide
1 other identifier
interventional
12
0 countries
N/A
Brief Summary
The purpose of this study is to examine the influence of artificial sweeteners (aspartame, acesulfame K, sucralose) and carbohydrate sugars (glucose, fructose) on the release of gastrointestinal satiety hormones in humans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1 healthy
Started Dec 2008
Typical duration for phase_1 healthy
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
September 16, 2009
CompletedFirst Posted
Study publicly available on registry
September 17, 2009
CompletedSeptember 17, 2009
September 1, 2009
3 months
September 16, 2009
September 16, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gastrointestinal peptide secretion
2 hour blood sampling
Study Arms (6)
Acesulfame K
ACTIVE COMPARATORSucralose
ACTIVE COMPARATORAspartame
ACTIVE COMPARATORGlucose
ACTIVE COMPARATORFructose
ACTIVE COMPARATORWater
PLACEBO COMPARATORInterventions
sweetening agent dissolved in tap water, administered via intragastric tube
Eligibility Criteria
You may qualify if:
- Healthy subject with a body-mass index of 19.0-24.5
- Normal eating habits
- Age 18-40 years
- Stable body weight for at least three months
You may not qualify if:
- Smoking
- Substance abuse
- Regular intake of medications (except for oral contraceptives)
- Medical or psychiatric illness
- history of gastrointestinal disorders
- food allergies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christoph Beglinger, MD
Clinical Research Center, University Hospital Basel
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 16, 2009
First Posted
September 17, 2009
Study Start
December 1, 2008
Primary Completion
March 1, 2009
Study Completion
July 1, 2009
Last Updated
September 17, 2009
Record last verified: 2009-09